Virbagen Lepto
Virbagen Lepto
Not authorised
This information is not available for this product.
Product identification
Medicine name:
Virbagen Lepto
Active substance:
This information is not available for this product.
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Germany
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac Tierarzneimittel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- PEI.V.04777.01.1
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 27/04/2022
